Table 3.
Clinicopathological characterization of samples from ovarian cancer patients.
| Patient ID | Tumor histologya | Surgeryb | EpCAM expression | TRAIL-R2 expression | ||
|---|---|---|---|---|---|---|
| STc | Ad | STc | Ad | |||
| 09 | Serous | Interval surgery | +++ | / | ++ | / |
| 10 | Serous | Interval surgery | +++ | / | + | / |
| 13 | Papillary serous | Primary surgery | / | +++ | / | +++ |
| 15 | Serous | Primary surgery | / | +++ | / | ++ |
| 16 | Serous | Primary surgery | / | +++ | / | ++ |
a
All ovarian cancers were grade 3.
b
Samples obtained after interval surgery had been exposed to chemotherapy; those obtained at primary surgery were chemo-naïve.
c
ST, ex vivo cells derived from solid tumors.
d
A, ex vivo cells derived from ascites.
/, Not available.
+, low expression; ++, average expression; +++, high expression.